The antiglycation activity test of peel off mask containing gold nanoparticles synthesized from kacip fatima extract (Labisia pumilla)
Abstract
Skin aging, which is influenced by intrinsic and extrinsic factors, can accelerate skin damage, with one of the main mechanisms being the glycation reaction that results in Advanced Glycation End Products (AGEs). AGEs are the result of indirect reaction between reducing sugars and amino acids, lipids, or proteins. This reaction is also known as the glycation reaction or the Maillard reaction. This research aims to develop a peel-off mask based on gold nanoparticles synthesized with Kacip Fatima extract as an anti-aging agent. Gold nanoparticles have the potential to inhibit the formation of AGEs and improve skin quality. In this study, gold nanoparticles were synthesized by the green synthesis method using Kacip Fatima extract as a reducing agent. The method used for gold characterization is by measuring the wavelength and absorbance, polydispersity index, and zeta potential value of gold nanoparticles. The method used for antiglycation is by using microplate reader, which is stored for 3 days and tested with excitation wavelength of 365 nm and emission wavelength of 415-445 nm. The characterization results showed that the gold nanoparticles had an average size of about 79.61 nm at week 0 and increased to 101.1 nm at week 9. Glycation testing revealed that masks with 20% gold nanoparticles inhibited glycation by up to 95%, higher than the concentration of 10%. This study successfully synthesized gold nanoparticles using Kacip Fatimah extract as a reducing agent, with particles ranging from 79.61 nm to 101.1 nm over 9 weeks. The nanoparticles showed antiglycation effects, with 10% nanoparticles inhibiting glycation by 78%, suggesting potential for environmentally friendly cosmetic applications like peel-off masks.
References
[2] M. Gkogkolou, “Advanced glycation end products (AGEs): Emerging skin aging mediators,” Textbook of Skin Aging, pp. 1675–1686, 2016. doi: 10.1007/978-3-662-47398-6_137.
[3] A. M. H. I. and B. R. Shai, Cosmetic Skincare Handbook, 2nd ed. Health Informa, London, 2013.
[4] M. Rinnerthaler, J. Bischof, M. K. Streubel, A. Trost, and K. Richter, “Oxidative stress in aging human skin,” Biomolecules, vol. 5, no. 2, pp. 545–589, Apr. 2015, doi: 10.3390/biom5020545.
[5] Jaafar, H. Z. E., & Ghasemzadeh, A. G. A. Karimi, “Chemical composition, antioxidant and anticancer potential of Labisia pumila alata variety under CO₂ enrichment,” NJAS - Wageningen Journal of Life Sciences, vol. 78, pp. 85–91, 2016.
[6] S. Kaul, N. Gulati, D. Verma, S. Mukherjee, and U. Nagaich, “Role of nanotechnology in cosmeceuticals: a review of recent advances,” J. Pharmaceutics, vol. 2018, no. 1, p. 3420204, 2018.
[7] D. Philip, “Rapid green synthesis of spherical gold nanoparticles using Mangifera indica leaf,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, vol. 77, no. 4, pp. 807–810, 2010. doi: 10.1016/j.saa.2010.08.008.
[8] Raval, N., Maheshwari, R., Kalyane, D., Youngren-Ortiz, S. R., Chougule, M. B., & Tekade, R. K, “Importance of physicochemical characterization of nanoparticles in pharmaceutical product development,” Basic Fundamentals of Drug Delivery, pp. 369–400, Netherlands: Elsevier, 2019.
[9] V. Spínola, J. Pinto, and P. C. Castilho, “Hypoglycemic, anti-glycation and antioxidant in vitro properties of two Vaccinium species from Macaronesia: A relation to their phenolic composition,” J. Funct. Foods, vol. 40, pp. 595–605, Jan. 2018.
[10] N. Raval, R. Maheshwari, D. Kalyane, S. R. Youngren-Ortiz, M. B. Chougule, and R. K. Tekade, “Importance of physicochemical characterization of nanoparticles in pharmaceutical product development,” Basic Fundamentals of Drug Delivery, pp. 369–400, Netherlands: Elsevier, 2019.
[11] Lu, G. W., & Gao, P, “Emulsions and microemulsions for topical and transdermal drug delivery,” Handbook of Non-Invasive Drug Delivery Systems, pp. 59–94, 2010. doi: 10.1016/b978-0-8155-2025.
[12] R. Nagarajan and T. A. Hatton, Nanoparticles: Synthesis, Stabilization, Passivation, Washington, DC, 2008.
[13] P. J. Thornalley, “Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts,” Arch. Biochem. Biophys., vol. 419, no. 1, pp. 31–40, Nov. 2003.
[14] S. M. B. Respati, “Macam-macam mikroskop dan cara penggunaan,” Momentum, vol. 4, no. 2, pp. 42–44, 2008.
[15] V. Spínola, J. Pinto, and P. C. Castilho, “Hypoglycemic, anti-glycation and antioxidant in vitro properties of two Vaccinium species from Macaronesia: A relation to their phenolic composition,” J. Funct. Foods, vol. 40, pp. 595–605, Jan. 2018.

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.
This licence applies to Author(s) and Public Reader means that the users mays :
- SHARE:
copy and redistribute the article in any medium or format - ADAPT:
remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication) - ALIKE:
If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original. - NO ADDITIONAL RESTRICTIONS:
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
It does however mean that when you use it you must:
- ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not:
- NONCOMMERCIAL: You may not use the article for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.



Tools
















